GRANT PICKERING - 30 Dec 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Chief Executive Officer, Director
Signature
Grant Pickering, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
30 Dec 2022
Net transactions value
+$30,771
Form type
4
Filing time
04 Jan 2023, 15:29:41 UTC
Previous filing
30 Sep 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $30,771 +15,158 +4.2% $2.03* 374,476 30 Dec 2022 Direct
holding PCVX Common Stock 157,830 30 Dec 2022 By Children's Trust F1
holding PCVX Common Stock 157,830 30 Dec 2022 By Children's Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Award $0 +108,250 $0.000000 108,250 30 Dec 2022 Common Stock 108,250 $47.95 Direct F3
transaction PCVX Stock Option (right to buy) Options Exercise $0 -15,158 -4.8% $0.000000 302,227 30 Dec 2022 Common Stock 15,158 $2.03 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
F2 Shares are held directly by a trust for the benefit of the Reporting Person's son.
F3 1/48 of shares subject to the option vest on January 30, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.
F4 Stock Option is fully vested and exercisable.